By blocking the interaction between tumor cells and immune checkpoints on T cells, such as CTLA-4 or PD-1/PDL1, the break on T cell inhibition is released, enabling activation, proliferation and the release of cytotoxins such as perforin and granzymes that eventually lead to apoptosis of tumor cells (5–7). The gene discussed is PRF1; the disease is neoplasm.